(Q31139732)

English

Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12/23p40 in a nonhuman primate model of multiple sclerosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

1 reference

Europe PubMed Central

Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12/23p40 in a nonhuman primate model of multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

author name string

Bert A 't Hart

1

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Rogier Q Hintzen

2

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Jon D Laman

3

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Neurodegenerative Diseases

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

38-52

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Tolerogenic dendritic cells

1 reference

https://api.crossref.org/works/10.1159%2F000109937

21 January 2018

Alternative activation of macrophages

1 reference

https://api.crossref.org/works/10.1159%2F000109937

21 January 2018

Self- and nonself-recognition by C-type lectins on dendritic cells

1 reference

https://api.crossref.org/works/10.1159%2F000109937

21 January 2018

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

1 reference

https://api.crossref.org/works/10.1159%2F000109937

21 January 2018

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

1 reference

https://api.crossref.org/works/10.1159%2F000109937

21 January 2018

Multiple sclerosis

1 reference

https://api.crossref.org/works/10.1159%2F000109937

21 January 2018

Transforming growth factor-beta induces development of the T(H)17 lineage

1 reference

https://api.crossref.org/works/10.1159%2F000109937

21 January 2018

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

1 reference

https://api.crossref.org/works/10.1159%2F000109937

21 January 2018

The CD40 antigen and its ligand

1 reference

https://api.crossref.org/works/10.1159%2F000109937

21 January 2018

Identifiers

10.1159/000109937

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31139732&oldid=1964392183"